Clinical Trials Logo

Nervous System Diseases clinical trials

View clinical trials related to Nervous System Diseases.

Filter by:

NCT ID: NCT05957783 Completed - Cerebral Palsy Clinical Trials

Changes in Upper Limb Kinematics in Children With Cerebral Palsy After Lower Limb Surgery

Start date: January 3, 2021
Phase:
Study type: Observational

İntroduction The upper limb can be involved in children with cerebral palsy (CP), while the lower limb is more commonly affected. Little is known regarding the alterations in the upper limb kinematics after the orthopedic surgery of the lower extremity during gait. This study aimed to evaluate the differences in the upper limb kinematics in children with CP between preoperative and postoperative parameters.

NCT ID: NCT05938452 Completed - Clinical trials for Neurological Disorder

Safety and Tolerability of Glyceryl Tribenzoate (GTB) Capsules in Healthy Subjects

Start date: December 12, 2022
Phase: Phase 1
Study type: Interventional

This study is designed to assess the safety and PK/PD of GTB and Benzoic Acid (Benzoate) using a single ascending dose (SAD) study (under fasting conditions).

NCT ID: NCT05895734 Completed - Multiple Sclerosis Clinical Trials

Effectiveness of Powerball System in People With Multiple Sclerosis

EMPOW
Start date: January 10, 2023
Phase: N/A
Study type: Interventional

There is a high percentage of impairment in the upper limbs (UL) in patients with multiple sclerosis (MS), being muscle strength and hand dexterity a determining factor for the preservation of functional activities, constituting the basis of independence and quality of life. The aim of this study is to determine the effects of a training protocol on UL muscle strength, through the NDS-Powerball® system, in combination with conventional physiotherapy, during 8 weeks in terms of muscle strength, coordination, fatigue, functionality and quality of life in people with MS.

NCT ID: NCT05830981 Completed - Clinical trials for Neurological Disorders

Valproic Acid Use in Patients With Neurological Disorders

Start date: January 1, 2015
Phase:
Study type: Observational

Sodium valproate is a well-known anticonvulsant used in the treatment of epilepsy and bipolar disorder, as well as other psychiatric conditions requiring the administration of mood stabilizers. Aim of the present study is to assess sodium valproate usage among patients with neurological disorders. Prescriptions of 600 patients from out-patient pharmacy of neurology department at Mansoura university teaching hospital were analyzed in a retrospective prospective observational study which conducted between January 2015 and December 2017. Data collected include: demographic data, medical history, drug-drug interaction, polypharmacy, medication error, doses and therapeutic duplication. A designed and structured form was used to collect the required information.

NCT ID: NCT05822557 Completed - Stroke Clinical Trials

Bolus Pouch Feed Study

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

The primary aim of this study is to evaluate the impact of introducing a new enteral tube feed on health and feeding related quality of life. Secondary aims are to assess ease of use, liking, compliance, gastrointestinal tolerance, nutrient intake, anthropometric changes and safety.

NCT ID: NCT05821257 Completed - Multiple Sclerosis Clinical Trials

Arm Swing During Walking in Early Multiple Sclerosis

Start date: December 1, 2021
Phase:
Study type: Observational

Multiple sclerosis (MS) is the most common central nervous system inflammatory demyelinating disease which causes motor and sensory deficits, cerebellar symptoms, and balance problems. Due to these symptoms, gait abnormalities are common in MS, even in patients with low degrees of impairment. The upper limb has an important role on postural control and gait stability. Affected arm swing movement and asymmetry during gait are common in neurological disorders such as Parkinson's disease (PD) even in early stages of the disease and arm swing treatment has been acknowledged to enhance gait and normalize arm swing in individuals with PD. The presence of arm swing changes during walking in MS patients, similar to PD, especially in the early period, may be an indicator of balance problems, this was, however, not investigated as such. Therefore, the aim of the current study is to assess the arm swing during gait in people with MS shortly after their diagnosis in early MS.

NCT ID: NCT05815836 Completed - Stroke Clinical Trials

Precision Medicine in Stroke

PROMISE
Start date: October 2013
Phase:
Study type: Observational

PROMISE aims at identifying novel diagnostic and prognostic circulating biomarkers for patients with acute stroke and at informing on crucial yet undetected pathophysiological mechanisms driving outcome after stroke by enriching all phenotypic information available from clinical routine with in-depth quantification of the circulating proteome and metabolome as well as other entities.

NCT ID: NCT05811689 Completed - Multiple Sclerosis Clinical Trials

Trabecular Bone Score in Multiple Sclerosis

Start date: February 14, 2021
Phase:
Study type: Observational

Assess bone quality in MS patients through TBS and evaluate the potential effects exerted by different drugs used in MS treatment, which may affect BMD and TBS in MS patients

NCT ID: NCT05737992 Completed - Parkinson Disease Clinical Trials

The Effect of Exercise in Water on Functional Fitness in People With Parkinson's Disease

Start date: April 10, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial study is to learn about the effect of aquatic exercise in parkinson's patients. The main questions it aims to answer are: - What is the effect of exercise in water on balance in parkinson's patients? - What is the effect of exercise in water on muscle strength in parkinson's patients? - What is the effect of exercise in water on flexibility in parkinson's patients? Parkinson's patients in this study will do some functional tests. One group of them will do exercises in water 3 times weekly for 8 weeks.

NCT ID: NCT05730842 Completed - Healthy Volunteer Clinical Trials

Absorption, Metabolism, Excretion and Absolute Bioavailability of EDG-5506 in Healthy Volunteers

Start date: January 12, 2023
Phase: Phase 1
Study type: Interventional

This is a Phase 1 2-part, single-center, open-label study in healthy male volunteers. Part A will assess the absorption, metabolism, excretion, and pharmacokinetics of one oral dose of radiolabeled EDG-5506. Part B will assess bioavailability of EDG-5506 with a single oral dose of EDG-5506 and a single intravenous dose of radiolabeled EDG-5506.